Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribokinase is an **enzyme** (EC 2.7.1.15) that catalyzes the phosphorylation of **D-ribose** to **D-ribose-5-phosphate** using **ATP** and magnesium as cofactors. This reaction is the **first step in ribose catabolism**, facilitating the entry of ribose into the **pentose phosphate pathway** and supporting the synthesis of nucleotides and histidine. Ribokinase belongs to the **phosphofructokinase B (PfkB) family**, also known as the RK family, which shares conserved sequence motifs and structural features. In humans, ribokinase (abbreviation: RK) is encoded by the RBKS gene. The enzyme's activity is essential for trapping ribose within the cell following uptake and for the metabolic recycling of ribose derived from nucleoside catabolism[1][2][3][4][5][6][8]. There are no well-established direct therapeutic drugs targeting ribokinase, nor are there clear safety issues or biomarker roles reported in current biomedical literature.
Substrate phosphorylation (transfers a phosphate group from ATP to D-ribose, producing D-ribose-5-phosphate)[1][2][5][8] - Magnesium ion dependence for activity[2][8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribokinase (RK).